Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +0.67% | -7.41% | -57.17% |
May. 14 | Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (TCON) TRACON PHARMACEUTICALS Posts Q1 Revenue $100,000 | MT |
Chart calendar TRACON Pharmaceuticals, Inc.
Upcoming events on TRACON Pharmaceuticals, Inc.
Past events on TRACON Pharmaceuticals, Inc.
2024-05-14 04:30 pm | Q1 2024 Earnings Call |
2024-05-14 04:01 pm | Q1 2024 Earnings Release |
2024-03-05 04:30 pm | Q4 2023 Earnings Call |
2024-03-05 04:02 pm | Q4 2023 Earnings Release |
2023-11-09 04:30 pm | Q3 2023 Earnings Call |
2023-11-09 04:02 pm | Q3 2023 Earnings Release |
2023-09-12 04:20 pm | Baird Global Healthcare Conference |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-09-06 11:00 am | Extraordinary Shareholders Meeting |
2023-08-14 04:30 pm | Q2 2023 Earnings Call |
2023-08-14 04:02 pm | Q2 2023 Earnings Release |
2023-06-20 03:30 pm | Maxim Group Virtual Healthcare Conference |
2023-06-09 08:30 am | Jefferies Global Healthcare Conference |
2023-06-05 02:15 pm | American Society of Clinical Oncology Conference - Abstract Number: 5564 |
2023-06-03 02:15 pm | American Society of Clinical Oncology Meeting - Abstract Number: TPS11583 |
2023-05-10 04:30 pm | Q1 2023 Earnings Call |
2023-05-10 04:02 pm | Q1 2023 Earnings Release |
2023-04-19 11:00 am | Annual General Meeting |
2023-03-08 04:30 pm | Q4 2022 Earnings Call |
2023-03-08 04:02 pm | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,35 0,36 -2.54% | 0,00 0,31 - | 12,0 10,5 14.71% | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -22,3 -23,8 6.27% | -16,2 -17,5 7.45% | -28,3 -27,6 -2.66% | -27,9 -29,8 6.49% | -9,27 -11,9 22.38% | -20,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,7 -24,3 6.74% | -16,8 -18,5 9.56% | -28,7 -27,8 -3.08% | -29,1 -30,2 3.55% | -3,59 -20,8 82.72% | -20,2 |
Net income Million USD | Released Forecast Spread | -22,7 -24,1 5.99% | -16,8 -18,0 7% | -28,7 -27,9 -2.72% | -29,1 -29,6 1.55% | -3,59 -12,8 71.95% | -20,2 |
EPS USD | Released Forecast Spread | -149 -159 6.16% | -37,4 -40,3 7.15% | -33,2 -32,5 -2.02% | -27,8 -27,9 0.18% | -2,20 -8,10 72.84% | -3,28 |
Announcement Date | 27/02/20 | 25/02/21 | 15/03/22 | 08/03/23 | 05/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 9,00 3,00 200% | 0,00 7,10 - | 3,05 1,50 103% | 0,10 0,00 - | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -9,45 -8,08 -16.88% | -6,24 -7,23 13.75% | -6,38 -6,71 4.9% | -5,83 -7,08 17.64% | -7,31 -6,87 -6.52% | -0,78 -4,78 83.72% | -1,59 1,47 -207.81% | 0,41 -2,27 117.95% | -3,21 -2,68 -19.76% | -4,85 | -5,26 | -5,46 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,47 -8,16 -16.06% | -6,23 -8,87 29.79% | -6,44 -6,96 7.59% | -7,00 -7,04 0.58% | -8,50 -6,65 -27.82% | -6,29 3,23 -294.88% | 10,8 1,47 630.69% | 0,44 -3,74 111.75% | -4,85 | -5,26 | -5,46 | |
Net income Million USD | Released Forecast Spread | -9,47 -8,12 -16.65% | -6,23 -7,25 14.01% | -6,44 -6,72 4.23% | -7,00 -6,77 -3.38% | -8,50 -6,73 -26.28% | -6,29 -0,73 -767.03% | 10,8 1,47 630.69% | 0,44 -2,27 119.36% | -3,17 -2,68 -18.12% | -4,85 | -5,26 | -5,46 |
EPS USD | Released Forecast Spread | -9,60 -8,35 -14.97% | -6,20 -7,15 13.29% | -6,00 -6,45 6.98% | -6,20 -6,20 0% | -7,20 -5,33 -35% | -4,00 -0,60 -566.67% | 5,80 1,00 480% | 0,20 -1,30 115.38% | -1,33 -1,18 -12.71% | -2,03 | -0,53 | -0,55 |
Announcement Date | 11/05/22 | 10/08/22 | 14/11/22 | 08/03/23 | 10/05/23 | 14/08/23 | 09/11/23 | 05/03/24 | 14/05/24 | - | - | - |
2024-07-11 02:00 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 02:00 am | BIOGAIA AB: Q2 2024 Earnings Release |
2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-25 01:00 am | UCB: Q2 2024 Earnings Release |
2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for TRACON Pharmaceuticals, Inc.
Today | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
2024-05-14 11:35 am | GRIFOLS, S.A.: Q1 2024 Earnings Release |
2024-05-12 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
2024-05-09 02:30 am | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
2024-05-08 04:16 pm | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TCON Stock
- Calendar TRACON Pharmaceuticals, Inc.